Hostname: page-component-6766d58669-l4t7p Total loading time: 0 Render date: 2026-05-20T22:44:10.195Z Has data issue: false hasContentIssue false
  • English
  • Français

Mitochondrial neurogastrointestinal encephalomyopathy associated with progressive hearing loss

Published online by Cambridge University Press:  15 June 2010

N Hiraki ,
T Udaka ,
H Yamamoto ,
Y Kadokawa ,
J Ohkubo  and
H Suzuki
N Hiraki*
Affiliation:
Department of Otorhinolaryngology, Hamamatsu Rosai Hospital, Hamamatsu, Japan
T Udaka
Affiliation:
Department of Otorhinolaryngology, Kumamoto Rosai Hospital, Yatsushiro, Japan
H Yamamoto
Affiliation:
Department of Otorhinolaryngology, Hamamatsu Rosai Hospital, Hamamatsu, Japan
Y Kadokawa
Affiliation:
Department of Otorhinolaryngology, Kumamoto Rosai Hospital, Yatsushiro, Japan
J Ohkubo
Affiliation:
School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
H Suzuki
Affiliation:
School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
*
Address for correspondence: Dr Nobuaki Hiraki, Department of Otorhinolaryngology, Hamamatsu Rosai Hospital, 25 Shogen-town, Naka-ku, Hamamatsu, 430-8525, Japan. Fax: +81 53 465 4380 E-mail: hiraki@med.uoeh-u.ac.jp
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

We report a rare case of mitochondrial neurogastrointestinal encephalomyopathy with hearing loss.

Case report:

A 46-year-old woman presented with a three-year history of progressive, bilateral hearing loss and tinnitus. She had been suffering from unexplained abdominal pain and diarrhoea for 20 years. When first seen, her otoscopic findings were normal, and pure tone audiometry showed mild and moderate hearing loss in her right and left ears, respectively. She also had: bilateral ophthalmoparesis, neck and limb muscle weakness, and hypoactive deep tendon reflexes on neurological examination; diffuse leukoencephalopathy on magnetic resonance imaging of the brain; and markedly reduced leukocyte thymidine phosphorylase activity. On the basis of these findings, the patient was diagnosed with mitochondrial neurogastrointestinal encephalomyopathy.

Conclusion:

Mitochondrial neurogastrointestinal encephalomyopathy is an autosomal recessive disease caused by mutation of the thymidine phosphorylase gene, and is characterised by ophthalmoparesis, peripheral neuropathy, leukoencephalopathy, gastrointestinal symptoms and abnormal mitochondria in muscle cells. Current advances in genetic research may reveal a higher prevalence of mitochondrial disorders than had previously been thought. Otolaryngologists should be aware of mitochondrial neurogastrointestinal encephalomyopathy and other rare genetic disorders when managing patients with progressive hearing loss.

Keywords

Mitochondrial Neurogastrointestinal EncephalomyopathySensorineural Hearing LossThymidine Phosphorylase

Information

Type
Clinical Records
Information
The Journal of Laryngology & Otology , Volume 124 , Issue 9 , September 2010 , pp. 1007 - 1009
Copyright
Copyright © JLO (1984) Limited 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1Nishino, I, Spinazzola, A, Hirano, M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999;283:689–92CrossRefGoogle ScholarPubMed
2Hirano, M, Silvestri, G, Blake, DM, Lombes, A, Minetti, C, Bonilla, E et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994;44:721–7CrossRefGoogle ScholarPubMed
3Zwirner, P, Wilichowski, E. Progressive sensorineural hearing loss in children with mitochondrial encephalomyopathies. Laryngoscope 2001;111:515–21CrossRefGoogle ScholarPubMed
4Elverland, HH, Torbergsen, T. Audiologic findings in a family with mitochondrial disorder. Am J Otol 1991;12:459–65Google Scholar
5Sue, CM, Lipsett, LJ, Crimmins, DS, Tsang, CS, Boyages, SC, Presgrave, CM et al. Cochlear origin of hearing loss in MELAS syndrome. Ann Neurol 1998;43:350–9CrossRefGoogle ScholarPubMed
6Berkovic, SF, Carpenter, S, Evans, A, Karpati, G, Shoubridge, EA, Andemann, F et al. Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study. Brain 1989;112:1231–60CrossRefGoogle ScholarPubMed
7Kaidar-Person, O, Golz, A, Netzer, A, Goldsher, D, Joachims, HZ, Goldenberg, D. Rapidly progressive bilateral sensory neural hearing loss as a presentation of mitochondrial neurogastrointestinal encephalomyopathy. Am J Otolaryngol 2003;24:128–30CrossRefGoogle ScholarPubMed
8Warrick, PD, Wardrop, P, Sim, DW. Sensorineural hearing loss in MELAS syndrome. J Laryngol Otol 1997;111:279–81CrossRefGoogle ScholarPubMed
9Millar, WS, Lignelli, A, Hirano, M. MRI of five patients with mitochondrial neurogastrointestinal encephalomyopathy. AJR Am J Roentgenol 2004;182:1537–41CrossRefGoogle ScholarPubMed